Dispensing, or the provision of insulin by the health system to an individual, faces two clear challenges in many LMICs [30, 31, 34]: (1) the often-large distance between communities and health facilities that provide diabetes care; and (2) the fact that insulin prescriptions may only be available from secondary or even tertiary healthcare facilities. This evidence concerns the gene INS and diabetes mellitus.